Regional differences in NPI efficacy and recommendations for Africa
Mollie M. Van Gordon
International Journal of Infectious Diseases · 2021
doi:10.1016/j.ijid.2021.09.044 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Non-pharmaceutical interventions (NPIs) remain a key component of COVID response, particularly in low- and middle-income countries (LMICs) where vaccination is limited (Padma 2021). Much of what we know about NPI efficacy, however, comes from HIC contexts, and this knowledge is not necessarily transferrable to LMICs (Chowdhury et al. 2020). It is well-established that lockdowns have had detrimental effects in LMICs, including increased food insecurity and diminished healthcare access (Amare et al. 2021; Harling et al. 2021).
Abstract licence: CC BY-NC-ND
References8
- 2.
7 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.